S'abonner

AtoG: A simple score to predict complications and death after hip fractures, in line with the comprehensive geriatric assessment - 26/04/24

Doi : 10.1016/j.otsr.2024.103827 
Baptiste Boukebous a, b, , David Biau a, c, Fei Gao d
a Université Paris Cité, équipe ECAMO, Centre of Research in Epidemiology and Statistics (CRESS), Inserm, UMR 1153, Paris, France 
b Service de chirurgie orthopédique et traumatologique, Beaujon/Bichat, université Paris Cité, AP–HP, Paris, France 
c Service de chirurgie orthopédique et traumatologique, Cochin, université Paris Cité, AP–HP, Paris, France 
d Recherche sur les Services et management en santé (RSMS) – U1309, université de Rennes, EHESP, CNRS, Inserm, Arènes – UMR 6051, 35000 Rennes, France 

Corresponding author: Service de chirurgie orthopédique et traumatologique, Beaujon/Bichat, 100, boulevard du Général-Leclerc, 92110 Clichy, France.Service de chirurgie orthopédique et traumatologique, Beaujon/Bichat100, boulevard du Général-LeclercClichy92110France

Abstract

Introduction

Proximal Femur Fractures (PFFs) are a significant public health issue and occur in the context of global frailty and aging. Recent literature identifies new patient-related prognostic factors that focus on socioeconomic environment, patient well-being, or nutrition status. Specific scores have been developed, but in most cases, they fail to be in line with the comprehensive geriatric assessment, or do not assess the newly identified prognostic factors, contain multitude collinearities, or are too complex to be used in the daily practice.

Hypothesis A comprehensive score with equal representation of the patient's dimensions does at least as good as the Charlson score (CCI), to predict complications and mortality.

Objective

To develop a new comprehensive prognostic score, predicting inpatient complications and mortality up to 5-year after PFF.

Material and methods

The patients treated surgically for PFF on a native hip, between 2005 and 2017 were selected from a French national database. The variables were the gender, age, the type of treatment (osteosynthesis or arthroplasty), and the CCI. The outcomes were the medical and surgical complications as inpatient and the mortality (up to 5-year). Variables were grouped into dimensions with similar clinical significance, using a Principal Component Analysis, for instance, bedsores and malnutrition. The dimensions were tested for 90-day mortality and complications, in regressions models. Two scores were derived from the coefficients: SCOREpond (strict ponderation), and SCORE (with loose ponderation: 1 point/risk factors, –1 point/protective factors). Calibration, discrimination (ROC curves with Area Under Curves AUC), and cross-validation were assessed for SCOREpond, SCORE, and CCI.

Results

Analyses were performed on 7756 fractures. The factorial analysis identified seven dimensions: age; brain-related conditions (including dementia): 1738/7756; severe chronic conditions (for instance, organ failures) 914/7756; undernutrition: 764/7756; environment, including social issues or housing difficulties: 659/7756; associated trauma: 814/7756; and gender. The seven dimensions were selected for the prognostic score named AtoG (ABCDEFG, standing for Age, Brain, Comorbidities, unDernutrition, Environment, other Fractures, Gender). The median survival rate was 50.8 months 95% CI [49–53]. Anaemia and urologic complications were the most prevalent medical complications (1674/7756, 21%, and 1109/7756, 14.2%). A total of 149/7756 patients (1.9%) developed a mechanical inpatient complication (fractures or dislocations), with a slightly higher risk for arthroplasties. The AUCs were 0.69, 0.68, and 0.67 for AtoGpond, AtoG, and CCI, respectively, for 90-day mortality, and 0.64, 0.63, and 0.56 for complications. Compared to patients with AtoG=0, Hazard Ratios for 90-day mortality were 2.3 95% CI [1.7–2.9], 4.2 95% CI [3.1–5.4], 6 95% CI [4.5–8.1], 8.3 95% CI [6.5–12.9], and 13.7 95% CI [8–24], from AtoG=1 to AtoG5, respectively (p<10–4); the 90-day survival decreased by 5%/point, roughly. The sur-risk of mortality associated with AtoG was up to 5-year: HR=1.51 (95% CI [1.46–1.55], p<10–4). Compared to AtoG=0, from AtoG=1 to AtoG5, the pooled Odd Ratios were 1.14 95% CI [1.06–1.2], 1.53 95% CI [1.4–1.7], 2.17 95% CI [1.9–2.4], 2.9 95% CI [2.4–3.4], and 4.9 95% CI [3.3–7.4] for any complication (p<10–4).

Conclusion

AtoG is a multidimensional score in line with the concept of comprehensive geriatric assessment. It had good discrimination and performance in predicting 90-day mortality and complications. Performances were as good as CCI for 90-day mortality, and better than it for the complications.

Level of proof

IV; retrospective cohort study.

Le texte complet de cet article est disponible en PDF.

Keywords : Proximal femur fractures, Osteoporotic fractures, Epidemiology, Comprehensive geriatric assessment


Plan


© 2024  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 110 - N° 3

Article 103827- mai 2024 Retour au numéro
Article précédent Article précédent
  • Uncemented hip revision cup as an alternative for T-type acetabular fractures: A cadaveric study
  • Adrian Cavalcanti Kußmaul, Jan Bruder, Axel Greiner, Matthias Woiczinski, Christoph Thorwächter, Fabian Dotzauer, Bianka Rubenbauer, Christoph Linhart, Wolfgang Böcker, Christopher A. Becker
| Article suivant Article suivant
  • Clinical characteristics of elderly hip fracture patients with chronic cerebrovascular disease and construction of a clinical predictive model for perioperative pneumonia
  • Yao Meng, Yan Liu, Mingming Fu, Zhiyong Hou, Zhiqian Wang

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.